Regulatory Press Releases
PILA PHARMA publishes interim report (1 January – 30 June 2024)
Malmö, 27 August, 2024 Download the press release as PDF here PILA PHARMA AB (publ) (FN STO: PILA) today publishes the Company´s interim report for the period January - June 2024. The report can be found on the Company´s website: https://pilapharma.com/investors/finansiell-information/ SUMMARY OF INTERIM REPORT First Half year (1 January - 30 June 2024) Operating income amounted to TSEK 683 (1…
PILA PHARMA’S BOARD OF DIRECTORS ANNOUNCES COMPLETION OF A FULLY SUBSCRIBED DIRECTED ISSUE OF APPROXIMATELY SEK 10 MILLION
Malmö, 25 July 2024 Download the press release as PDF here NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD…
PILA PHARMA INKS AGREEMENT WITH LINDUS HEALTH ABOUT NEXT CLINICAL TRIAL WITH SAFETY AND OBESITY READOUTS
Malmö, 24 July 2024 Download the press release as PDF here PILA PHARMA AB (publ) (FN STO:PILA) today announces it has entered into agreement with a United Kingdom based clinical research organisation, Lindus Health, on supply of clinical research services to assist with the submission of an clinical trial application for approval for PP-CT03, a phase 2a study in obese people…
PILA PHARMA’S BOARD OF DIRECTORS HAS RESOLVED TO CARRY OUT A DIRECTED ISSUE OF SHARES OF APPROXIMATELY SEK 10.0 MILLION
Malmö, 16 July 2024 Download the press release as PDF here NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD…
PILA PHARMA AB APPOINTS NEW CHAIRMAN OF THE BOARD AND CEO
Malmö, 19 april 2024 Download the press release as PDF here Following the election yesterday of Dorte X. Gram as new Chairman of the Board of Pila Pharma AB (publ) (FN STO: PILA) she simultaneously has stepped down as CEO. The newly elected Board of Directors has subsequently appointed Gustav H. Gram as new CEO and Dorte X. Gram as Chief…